Michelle Lai

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

A Survey of Liver Transplantation from Living Adult Donors in the United States

Robert S. Brown, Mark W. Russo, Michelle Lai et al. · New England Journal of Medicine · 2003 · 486 citations · Full text

Medicine, Surgery, Hepatology +14

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

Samer Gawrieh, Mazen Noureddin, Nicole Loo et al. · Hepatology · 2021 · 356 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase

Phillip J. White, Robert W. McGarrah, Paul A. Grimsrud et al. · Cell Metabolism · 2018 · 352 citations · Full text

Life Sciences, Biochemistry, Enzymology +10